Eli Lilly and Company Company Profile

Lilly Corporate Center		Tel: +1 317 276 2000
Indianapolis, IN 46285		Fax: +1 317 277 6579

United States		www.lilly.com
North America

Date of Establishment	1876
Employees	38,350
Ticker Symbol	New York: LLY
SIC Codes	2833 2834
Sector	Pharmaceuticals


Eli Lilly and Company Principal Activities and Company Overview
Eli Lilly and Company researches, develops, manufactures and distributes pharmaceuticals. The Company's principal products include neuroscience, endocrine, oncology and animal health products. The Company also manufactures cardiovascular agents, anti-infectives and other pharmaceutical products.

Eli Lilly and Company Board of Directors
John C Lechleiter, Chairman, President and Chief Executive Officer Ralph Alvarez, Director Sir Winfried Bischoff, Director Michael L Eskew, Director Martin S Feldstein, Director J Erik Fyrwald, Director Alfred G Gilman, Director R. David Hoover, Director Karen N Horn, Director Ellen R Marram, Director Douglas R Oberhelman, Director Franklyn G Prendergast, Director Kathi P Seifert, Director

Eli Lilly and Company Leadership, Senior Decision Makers and Key Executives
John C. Lechleiter, Chairman, President and Chief Executive Officer E. Paul Ahern, Vice President, Global API Manufacturing Robert A. Armitage, Senior Vice President and General Counsel Robert W. Armstrong, Vice President, Global External Research and Development, Lilly Research Laboratories Alex M. Azar II, Vice President of Business-to-Business and Puerto Rico for Lilly USA Jack Bailey, Senior Vice President, Account-Based Markets, Lilly USA Karim Bitar, President, European Operations Thomas F. Bumol, Vice President, Biotechnology Discovery Research Bryce D. Carmine, Executive Vice President and President, Lilly Bio-Medicines William W. Chin, Vice President, Discovery Research and Clinical Investigation Enrique Conterno, Senior Vice President and President, Lilly Diabetes Newton F. Crenshaw, Vice President, Global Public Policy, Pricing, Reimbursement & Access (PRA), and International Corporate Affairs Maria Crowe, Vice President, Drug Product Manufacturing Andrew M. Dahlem, Vice President, LRL Operations Frank M. Deane, President, Manufacturing Operations Alecia A. DeCoudreaux, Vice President and General Counsel Johanna Carmel Egan, Vice President, Project Management Stephen F. Fry, Senior Vice President, Human Resources and Diversity Timothy J. Garnett, Chief Medical Officer � Vice President, Global Medical, Regulatory and Safety Thomas W. Grein, Vice President and Treasurer William F. Heath Jr, Vice President, Product Research and Development Michael C. Heim, Vice President, Information Technology and Chief Information Officer Peter J. Johnson, Executive Director, Corporate Strategic Planning Elizabeth H. Klimes, Vice President, Six Sigma Jan M. Lundberg, Executive Vice President, Science and Technology, and President, Lilly Research Laboratories Sue Mahony, Senior Vice President, and President, Lilly Oncology Patricia Martin, Vice President, Global Diversity W. Darin Moody, Vice President, Corporate Engineering and Continuous Improvement Anthony (Tony) Murphy, Senior Vice President, Human Resources Anne Nobles, Chief Ethics and Compliance Officer, and Senior Vice President, Enterprise Risk Management Elizabeth G. O'Farrell, Vice President and Controller Steven M. Paul, Executive Vice President, Science and Technology President, Lilly Research Laboratories Bart Peterson, Vice President of Corporate Affairs and Communications Derica W. Rice, Senior Vice President and Chief Financial Officer Gino Santini, Senior Vice President, Corporate Strategy and Business Development Jeffrey Simmons,Senior Vice President, and President, Elanco Animal Health Jacques Tapiero, Senior Vice President, and President, Emerging Markets Thomas Verhoeven, President, Global Product Development Fionnuala Walsh, Vice President, Quality James A. Ward, Vice President and Chief Procurement Officer Andreas Witzel, Vice President, Drug Product Manufacturing Operations for Europe and Asia Alfonso Zulueta, President and General Manager, Lilly Japan

Full Eli Lilly and Company company profile includes*:-
	Selected financial information over 10 years to include revenue, profit before tax, net income, shareholders' equity, total assets, earnings per share and dividends per share
	Eli Lilly and Company Full Contact Details
	Eli Lilly and Company Analyst Coverage
	Eli Lilly and Company snapshot data and quick facts Consolidated and condensed data and quick facts such as revenues by segment, market share, geographical segment information, return on equity, R&D expenditure etc
	Eli Lilly and Company List of Competitors
	Eli Lilly and Company Board of Directors
	Eli Lilly and Company Key Management & Decision Makers
	Eli Lilly and Company Executive Biographies
	Eli Lilly and Company Activities Overview and Company Background
	Eli Lilly and Company Office and Location Directory
	Eli Lilly and Company Tradenames
	Eli Lilly and Company Date of establishment
	Eli Lilly and Company Number of employees
	Eli Lilly and Company SIC codes
	Eli Lilly and Company Ticker symbol / company type
	* where available